Jump to content

Definition:New business value

From Insurer Brain

🏷️ New business value represents the expected economic profit, measured at the point of sale, generated by life insurance and savings contracts written during a given reporting period. It captures the present value of all projected future profits attributable to newly acquired policies — after accounting for the cost of required regulatory capital, expected claims, commissions, expenses, and the time value of money. As a forward-looking indicator, new business value sits at the heart of the embedded value reporting framework used by life insurers across Europe, Asia, and other major markets to communicate value creation to shareholders.

📐 Calculating new business value involves projecting the cash flows that a cohort of newly sold policies will produce over their lifetime, applying assumptions for persistency, mortality, morbidity, investment returns, and expenses, then discounting those cash flows at a rate that reflects the risks involved. The discount rate methodology differs depending on the valuation framework: traditional embedded value uses a single risk-adjusted discount rate, while market consistent embedded value relies on risk-free rates plus explicit adjustments for non-hedgeable risks. Sensitivities to key assumptions — interest rates, lapse rates, and expense inflation — are typically disclosed alongside the headline figure, giving stakeholders a window into how volatile the metric may prove. Under IFRS 17, the analogous concept at inception is the contractual service margin recognized for each group of contracts, though the two measures are constructed differently and are not directly interchangeable.

🌐 For life insurers, new business value functions as the primary gauge of growth quality — it answers the question of whether new sales are actually adding economic value or merely adding volume. A company that grows premium rapidly but with thin or negative new business value is effectively destroying shareholder capital, a pattern that has afflicted insurers in highly competitive savings and annuity markets. Conversely, strong new business value growth, especially when paired with a healthy new business margin, signals disciplined pricing and a favorable product mix. Analysts following major life groups globally — from European composites to large Chinese life insurers — treat new business value as perhaps the single most important metric for assessing management's ability to allocate capital and create long-term value.

Related concepts: